# Periodontitis and peripheral artery disease: a mini-review

**Authors:** Domenico De Falco, Sergio Zacà, Margot Ringold, Francesca Sodero, Domenico Angiletta, Massimo Petruzzi

PMC · DOI: 10.3389/froh.2026.1728706 · Frontiers in Oral Health · 2026-01-23

## TL;DR

This mini-review explores the possible link between periodontitis and peripheral artery disease, suggesting a modest association that may be stronger with shared risk factors.

## Contribution

The paper synthesizes recent studies to highlight the relationship between periodontitis and PAD, emphasizing the need for better-designed research.

## Key findings

- Most reports support a modest association between periodontitis and PAD.
- Oral pathogens like Porphyromonas gingivalis are found in PAD patients.
- Shared risk factors like diabetes and smoking strengthen the observed association.

## Abstract

Periodontitis is a inflammatory disease characterized by progressive loss of periodontal attachment and alveolar bone, leading to tooth mobility and eventual tooth loss. Periodontal disease affects about half of U.S. adults. Epidemiologic evidence links periodontitis to increased incidence of cardiovascular disease (CVD). Peripheral artery disease (PAD) is common in adults aged ≥65 years and is associated with substantially increased cardiovascular risk. It is an atherosclerotic condition that shares major risk factors, diabetes, smoking, older age, hypertension, and chronic kidney disease. Although the link between periodontitis and CVD is well established, comparatively few studies have examined PAD specifically. This mini-review synthesizes recent studies on periodontitis and PAD. Across heterogeneous designs and populations, most reports support a modest association, which appears stronger in the presence of shared risk factors (e.g., diabetes, smoking) and with more severe periodontal involvement. Several studies have detected oral pathogens or pathogen-specific antibodies (e.g., Porphyromonas gingivalis, Treponema denticola) in patients with PAD and report higher circulating inflammatory mediators. Nonetheless, substantial heterogeneity in populations, exposure/outcome definitions, and confounding control, and the likelihood of residual confounding, limit causal inference. Large, well-designed prospective studies with standardized periodontal phenotyping and rigorous adjustment (including attention to temporal trends in dental extraction practices) are needed to define effect magnitude and clinical relevance.

## Linked entities

- **Diseases:** periodontitis (MONDO:0005076), cardiovascular disease (MONDO:0004995), diabetes (MONDO:0005015), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** tooth loss (MESH:D016388), Periodontitis (MESH:D010518), hypertension (MESH:D006973), chronic kidney disease (MESH:D051436), inflammatory (MESH:D007249), atherosclerotic condition (MESH:D050197), diabetes (MESH:D003920), PAD (MESH:D058729), CVD (MESH:D002318), Periodontal disease (MESH:D010510)
- **Species:** Homo sapiens (human, species) [taxon 9606], Porphyromonas gingivalis (species) [taxon 837], Treponema denticola (species) [taxon 158]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876158/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876158/full.md

---
Source: https://tomesphere.com/paper/PMC12876158